Literature DB >> 10461363

Relationship of ECL cells and gastric neoplasia.

H L Waldum1, E Brenna, A K Sandvik.   

Abstract

The enterochromaffin-like (ECL) cell in the oxyntic mucosa has a key role in the regulation of gastric secretion since it synthesizes and releases the histamine regulating the acid secretion from the parietal cell. Gastrin is the main regulator of the ECL cell function and growth. Long-term hypergastrinemia induces ECL cell hyperplasia, and if continued, neoplasia. ECL cell carcinoids occur in man after long-term hypergastrinemia in conditions like pernicious anemia and gastrinoma. There is also accumulating evidence that a proportion of gastric carcinomas of the diffuse type is derived from the ECL cell. Furthermore, the ECL cell may, by producing substances with angiogenic effects (histamine and basic fibroblast growth factor), be particularly prone to develop malignant tumors. Although the general opinion is that gastrin itself has a direct effect on the oxyntic mucosal stem cell, it cannot be excluded that the general trophic effect of gastrin on the oxyntic mucosa is mediated by histamine or other substances from the ECL cell, and that the ECL cell, therefore, could play a role also in the tumorigenesis/carcinogenesis of gastric carcinomas of intestinal type.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10461363      PMCID: PMC2578987     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  72 in total

1.  The effect of prolonged histamine stimulation on the parietal cell population and the secretory function of the guineapig stomach.

Authors:  I N MARKS
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1957-04

2.  Case of metastasizing carcinoma (argentaffinoma?) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxy-tryptamine in blood and urine.

Authors:  B PERNOW; H SILWER; J WALDENSTROM
Journal:  Acta Med Scand       Date:  1956-12-08

3.  Non-proliferative capacity of endocrine cells of the human gastro-intestinal tract.

Authors:  H L Waldum; E Brenna
Journal:  Histochem J       Date:  1996-05

4.  Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Authors:  H Larsson; E Carlsson; R Håkanson; H Mattsson; G Nilsson; R Seensalu; B Wallmark; F Sundler
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

Review 5.  The carcinoid. A collective review.

Authors:  S L Teitelbaum
Journal:  Am J Surg       Date:  1972-05       Impact factor: 2.565

6.  Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmoset.

Authors:  C T Eason; A J Spencer; A Pattison; D D Howells; D C Henry; F W Bonner
Journal:  Toxicol Appl Pharmacol       Date:  1988-09-15       Impact factor: 4.219

7.  Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation.

Authors:  A Ooi; H Hayashi; S Katsuda; I Nakanishi
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

8.  Somatostatin cells in the oxyntic mucosa of hypo- or hypergastrinemic rats.

Authors:  D Chen; A Uribe; R Håkanson; F Sundler
Journal:  Scand J Gastroenterol       Date:  1992-06       Impact factor: 2.423

9.  Composite gastric carcinoid and adenocarcinoma.

Authors:  M H Ali; A Davidson; J G Azzopardi
Journal:  Histopathology       Date:  1984-05       Impact factor: 5.087

10.  Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats.

Authors:  R Håkanson; Y Tielemans; D Chen; K Andersson; H Mattsson; F Sundler
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

View more
  15 in total

1.  Neuroendocrine gastric carcinoma expressing somatostatin: a highly malignant, rare tumor.

Authors:  Jaques Waisberg; Leandro Luongo de Matos; Ana Maria do Amaral Antonio Mader; Sergio Pezzolo; Esmeralda Miristene Eher; Vera Luiza Capelozzi; Manlio Basilio Speranzini
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

Review 2.  Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion.

Authors:  Guanglin Cui; Helge L Waldum
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 3.  Antiulcer drugs and gastric cancer.

Authors:  Helge L Waldum; Bjørn Gustafsson; Reidar Fossmark; Gunnar Qvigstad
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

4.  Second primary malignancies in patients with neuroendocrine tumors.

Authors:  J J Reina; R Serrano; M Codes; E Jiménez; M Bolaños; E Gonzalez; I Sevilla
Journal:  Clin Transl Oncol       Date:  2014-05-01       Impact factor: 3.405

5.  Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies.

Authors:  Andreas Tartaglia; Guida M Portela-Gomes; Kjell Oberg; Paolo Vezzadini; Maria P Foschini; Mats Stridsberg
Journal:  Virchows Arch       Date:  2006-01-12       Impact factor: 4.064

6.  Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications.

Authors:  Cigdem Celikel; Funda Eren; Bahadir Gulluoglu; Nural Bekiroglu; Serdar Turhal
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

7.  Activation of the calcium sensing receptor stimulates gastrin and gastric acid secretion in healthy participants.

Authors:  L Ceglia; S S Harris; H M Rasmussen; B Dawson-Hughes
Journal:  Osteoporos Int       Date:  2008-06-07       Impact factor: 4.507

8.  Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.

Authors:  Funda Eren; Ciğdem Celikel; Bahadir Güllüoğlu
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

Review 9.  Gastrin and Gastric Cancer.

Authors:  Helge L Waldum; Liv Sagatun; Patricia Mjønes
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-17       Impact factor: 5.555

10.  Refractory thrombocytopenia responds to octreotide treatment in a case of evans syndrome with gastric neuroendocrine tumor.

Authors:  Kocfa Chung-Delgado; Alejandro Revilla-Montag; Sonia Guillén-Bravo; Hugo Ríos-Díaz; José C Alva-Muñoz
Journal:  Case Rep Hematol       Date:  2013-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.